Moderna says its COVID vaccine highly effective in late trial
Published
Company is second in U.S. to report extremely promising results. Pfizer did a week ago.
Full ArticlePublished
Company is second in U.S. to report extremely promising results. Pfizer did a week ago.
Full ArticleCambridge biotech Moderna Inc. will submit its first-ever application for drug approval today after new trial data shows its..
In a statement on Thursday, CEO Pascal Soriot of AstraZeneca plc (LON: AZN) expressed plans of launching a new global trial that..